Method and apparatus for coagulation based assays

• US 6,451,610 B1
• Filed: 04/14/1999
• Issued: 09/17/2002
• Est. Priority Date: 04/14/1999
• Status: Active Grant

• Current Assignee: International Technidyne Corporation (Sphingotec GMBH)
• Original Assignee: International Technidyne Corporation (Sphingotec GMBH)
• Inventors: Gorman, John, Gorman, Anne Jessica, Samo, Robert
• Primary Examiner(s): WALLENHORST, MAUREEN
• Application Number:
  US09/291,776
• Time in Patent Office: 1,252 Days
• Field of Search: 436/63, 436/69, 436/164, 436/165, 422/55, 422/58, 422/73, 422/99, 422/102, 73/644.1, 73/644.3, 600/369, 435/13, 356/244, 356/246
• US Class Current: 436/69
• CPC Class Codes: G01N 33/5302 Apparatus specially adapted for immunological test procedures
• CPC Class Codes: G01N 33/86 involving blood coagulating time or factors, or their receptors

Abstract

An activated partial thromboplastin time (APTT) test is described which employs fresh, whole blood that has not been anticoagulated. The method employs a disposable cuvette having specific reagents placed therein. A sample of whole blood is introduced into the cuvette which is drawn into at least one conduit by a pneumatic pump. Initially, the calcium in the sample is chelated at a first reaction site in the conduit, and thereafter is moved through the conduit to a second reaction site where the sample is coagulated by an APTT reagent. After a predetermined incubation time, the sample is moved to a third reaction site where it is recalcified. Clotting time is measured from the time that the sample is recalcified to the time that clot formation is visibly detected.

Claims

1. A method of performing a coagulation-based assay on a fresh whole blood sample, comprising the steps of:

providing a cuvette having at least one substantially non-capillary conduit having a first end and a second end, said at least one conduit having a restriction disposed between said first end and said second end of said conduit;

introducing a predetermined volume of said blood sample into said first end of said at least one conduit;

providing an anticoagulating agent at a first position in said at least one conduit, wherein said anticoagulating agent is capable of mixing with said blood sample;

providing a coagulation agent in a second position in said at least one conduit, a portion of said conduit between said first position and said second position curving in a half-circle formation, wherein said coagulation reagent is capable of mixing with said blood sample;

providing a recalcification agent at a third position in said at least one conduit, said third position located between said restriction and said second end of said at least one conduit, wherein said recalcification agent is capable of mixing with said blood sample;

moving said blood sample from said first position to said second position, and from said second position to said third position; and

measuring the time it takes for said blood sample to clot.

2. The method according to claim 1, wherein the anticoagulating agent is selected from the group consisting of citrates, amino carboxylates, oxalates and heparin.

3. The method according to claim 2, wherein the anticoagulating agent comprises a citrate.

4. The method according to claim 3, wherein the anticoagulating agent is selected from the group consisting of sodium citrate, trisodium citrate, and potassium citrate.

5. The method according claim 1, wherein the coagulation agent is selected from the group consisting of diatomaceous earth, kaolin, ellagic acid, silica, celite, phospholipids, and mixtures thereof.

6. The method of claim 1, wherein the recalcification agent is selected from the group consisting of calcium chloride, calcium gluconate, calcium glycine, and calcium imidodiacetate.

7. The method according to claim 1, wherein said blood sample is moved by pneumatic pumping.

8. A method of performing a coagulation-based assay on a fresh whole blood sample, comprising the steps of:

providing a cuvette having at least one substantially non-capillary conduit, said at least one conduit having a first end and a second end, wherein at least one restriction is disposed between said first end and said second end of said conduit;

introducing a predetermined volume of said blood sample into said first end of said at least one conduit;

providing a calcium chelating agent at a first position in said at least one conduit in a predetermined amount, wherein said calcium chelating agent mixes with said blood sample for a predetermined period of time;

moving said calcium chelated blood sample along said at least one conduit to a second position, a portion of said conduit between said first position and said second position curving in a half-circle formation;

providing a coagulation agent at said second position in said at least one conduit in a predetermined amount, wherein said coagulation agent mixes with said calcium chelated blood sample for a predetermined period of time;

moving said coagulated blood sample along said at least one conduit to a third position;

providing a recalcification agent at said third position in said at least one conduit in a predetermined amount, said third position located between said at least one restriction and said second end of said at least one conduit, wherein said coagulated blood sample contacts said recalcification agent; and

measuring the time it takes for said blood sample to clot.

9. The method according to claim 8, wherein the calcium chelating agent is selected from the group consisting of citrates, amino carboxylates, oxalates, and heparin.

10. The method according to claim 8, wherein the calcium chelating agent comprises a citrate.

11. The method according to claim 10, wherein the calcium chelating agent is selected from the group consisting of sodium citrate, trisodium citrate, and potassium citrate.

12. The method according to claim 8, wherein the coagulation agent is selected from the group consisting of diatomaceous earth kaolin, ellagic acid, silica, celite, phospholipids, and mixtures thereof.

13. The method according to claim 8, wherein the recalcification agent is selected from the group consisting of calcium chloride, calcium gluconate, calcium glycine, and calcium imidodiacetate.

14. The method according to claim 8, wherein said blood sample is moved by pneumatic pumping.

15. The method according to claim 8, wherein said predetermined period of time wherein said calcium chelating agent mixes with said blood sample is about 30 seconds.

16. The method according to claim 8, wherein said predetermined period of time wherein said coagulation agent mixes with said calcium chelated blood sample ranges from about three to five minutes.

21. The method according to claim 11, wherein the coagulation agent is selected from the group, consisting of diatomaceous earth, kaolin, ellagic acid, silica, celite, phospholipids, and mixtures thereof.

17. A method of performing an activated partial thromboplastin time test on a fresh whole blood sample, comprising the steps of:

providing a cuvette having at least one substantially non-capillary conduit having a first end and a second end, wherein at least one restriction is disposed between said first end and said second end of said at least one conduit;

introducing a predetermined volume of said blood sample into said first end of said at least one conduit of said cuvette;

providing an anticoagulating agent at a first position in said at least one conduit, wherein said anticoagulating agent mixes with said blood sample for a predetermined period of time to chelate calcium present in said blood sample;

moving said anticoagulated blood sample along said at least one conduit to a second position, a portion of said conduit between said first position and said second position curving in a half-circle formation;

providing a coagulation agent at said second position in said at least one conduit, wherein said coagulation agent mixes with said anticoagulated blood sample for a predetermined period of time to allow activation of deficiency factors and coagulation of said blood sample;

providing a recalcification agent at a third position in said at least one conduit, said third position located between said at least one restriction and said second end of said at least one conduit;

moving said coagulated blood sample through said at least one restriction to said third position, wherein said coagulated blood sample contacts and is recalcified by said recalcification agent; and

measuring the time it takes for said blood sample to clot from the time the coagulated blood sample contacts said recalcification agent to the time that said at least one restriction in said cuvette is blocked by a clot formation.

18. The method according to claim 17, wherein the anticoagulating agent is selected from the group consisting of citrates, amino carboxylates, oxalates, and heparin.

19. The method according to claim 18, wherein the anticoagulating agent comprises a citrate salt.

20. The method according to claim 19, wherein the anticoagulating agent is selected from the group consisting of sodium citrate, trisodium citrate, and potassium citrate.

22. The method according to claim 17, wherein the recalcification agent is selected from the group consisting of calcium chloride, calcium gluconate, calcium glycine, and calcium imidodiacetate.

23. The method according to claim 17, wherein said blood sample is moved by pneumatic pumping.